1267 |
Importance of Endpoint Adjudication (Clinical Events Committees) and Core Laboratories |
Donald E. Cutlip |
May. 04. 10 |
1266 |
Nuances of Clinical Trials: Trial Size, Power Analysis, Sub Groups |
David Joel Cohen |
May. 04. 10 |
1265 |
Types of Clinical Trials in Cardiology: The Rationale for Trial Design |
Roxana Mehran |
May. 04. 10 |
1264 |
From DES to Percutaneous Valves: What Interventional Doctors Need to Know about Regulatory Barriers and Solutions to Global Device Evaluation |
Mitchell W. Krucoff |
May. 04. 10 |
1263 |
Experience and Opportunities for Asia-PAC in Global Device Studies |
Takaaki Isshiki |
May. 04. 10 |
1262 |
Global Evaluation of Left Main PCI: The Time Has Come |
Chuck Simonton |
May. 04. 10 |
1261 |
The Platinum DES Study: A Manufacturer¡¯s View of Global Device Study |
Keith D. Dawkins |
May. 04. 10 |
1260 |
FFR Evalution of Bifurcating Lesion |
Bon-Kwon Koo |
May. 04. 10 |
1259 |
Practical Aspects in FFR; When, Why and How to Use? |
William A. Gray |
May. 04. 10 |
1258 |
The Next Generation Plaque Images: C7 FD-OCT / Infrared Spectroscopy |
Ik-Kyung Jang |
May. 04. 10 |